Pfizer is cutting costs, growing its core business, and trading at a deep discount despite looming patent losses and COVID ...

UT Dell Medical School study helps solve question of when to start blood thinners after a stroke in someone with AFib.

AstraZeneca’s top medical executive Cristian Massacesi will replace Bristol Myers’ current chief medical officer, Samit ...